Skip to main content

Table 3 Relation between transplant outcomes and severity of upper GI symptoms

From: Evaluation of gastrointestinal complications in Egyptian patients after autologous stem cell transplantation using melphalan-based regimens

Outcome

Upper GI symptoms  < grade 2

(n = 28)

Upper GI symptoms  ≥ grade 2

(n = 19)

p value

Overall survival (month)

9(3–30)

9(3–32)

0.819

Neutropenic fever (days)

5(4–9)

8(4–13)

0.001

Neutrophil engraftment (days)

14(10–17)

19(11–30)

0.001

Platelet engraftment (days)

16(13–25)

22(17–36)

0.001

Days on antibiotics beyond prophylaxis

5(4–9)

6(4–10)

0.603

Duration of hospital stay (days)

19(17–25)

26(22–33)

0.041

RBCs transfusion (unit)

1(0–4)

3(1–4)

0.001

Platelet transfusion (unit)

12(6–36)

28(12–40)

0.001

Weight reduction from admission (kg)

3(0–5)

5(1–8)

0.001

Electrolyte imbalance

  

0.001

 Negative

21(75)

0(0)

 Hypokalemia

6(21.4)

11(57.9)

 Hypokalemia plus hypomagnesemia

1(3.6)

8(42.1)

Hypoalbuminemia

  

0.155

 No

24(85.7)

13(68.4)

 Yes

4(14.3)

6(31.6)

Renal impairment

  

0.163

 No

25(89.3)

14(73.7)

 Yes

3(10.7)

5(26.3)

  1. Values are expressed as median (range) and n (%)